Eli Lilly’s weight loss drugs trounce sky-high expectations, boosting the stock
The weight loss medication market is shaping up to be a duopoly of Eli Lilly and Novo Nordisk, analysts said.
Source link
- Apple uploads entire first episode of ‘Silo’ on Twitter ahead of season finale
- Delta CEO forecasting highest Q2 earnings ever. Here’s what the pros are saying
